International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Evaluation of Biochemical Parameters in Controlled and Uncontrolled Type-2 Diabetic Patients of Bangladesh

    , , , ,

Author Affiliations

  • 1Department of Bio Chemistry and Molecular Biology, University of Chittagong, Chittagong-4331 BANGLADESH
  • 2Chittagong Diabetic General Hospital, Chittagong-4000, BANGLADESH

Int. Res. J. Biological Sci., Volume 3, Issue (3), Pages 19-22, March,10 (2014)

Abstract

Type 2 Diabetes mellitus is one of the most serious public health problems, faced by both developed and developing countries. Patients with type 2 diabetes often show an unusual biochemical profile. Glycosylated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control. In accordance with its function as an indicator for the mean blood glucose level, HbA1c predicts the risk for the development of diabetic complications in diabetic patients. Therefore the aim of the present study was to investigate the evaluation of biochemical parameters in controlled and uncontrolled type 2 diabetic patients on the basis of glycosylated hemoglobin (HbA1c) level as a control. Venous blood samples collected from 156 subjects (Controlled 45 and Uncontrolled 111) with type 2 diabetes mellitus and serum analyzed for HbA1c, Fasting and after breakfast blood glucose, Total Cholesterol, Triglycerides, HDL, LDL and Electrolytes. All biochemical parameters were measured following standard analytical procedure. The HbA1c and after breakfast glucose level were significantly higher in uncontrolled groups than controlled type 2 diabetic subjects (p0.001 and p0.01respectively). Serum triglyceride level in uncontrolled groups was significantly higher than controlled type 2 diabetic patients (p0.009). Serum Na and Clwas significantly higher (p0.05) in the controlled compared to uncontrolled subjects. Total cholesterol and triglycerides showed significant positive correlation with HbA1c (p0.00 and p0.01 respectively). Cl is negatively correlated with HbA1c and triglyceride (p0.045 and p0.022 respectively). The present study showed thatlipid level is increased and electrolytes level is decreased in uncontrolled type 2 diabetes mellitus and HbA1c may be utilized for early diagnosis of cardiovascular disease and timely intervention with lipid lowering drugs in Type 2 diabetic patients.

References

  1. Kannel W.B, McGee D., Diabetes and cardiovascular risk factors: the Framingham study, Circulation., 59(1),8–13(1979)
  2. Ronald M., Lipid and lipoproteins in type 2 diabetes, Diabetes Care., 27(6),1496-504 (2004)
  3. Tushuizen M, Diamant M, Heine R., Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes, Postgrad Med J.,81,1-6(2005)
  4. Bevan J.L., Diabetes mellitus: a review of select ADA standards for 2006. J Nurse Pract, 2(10), 674-679 (2006)
  5. Middleton J., The effect of case management on glycemic control in patients with type 2 diabetes, The Case Manager, 14(6), 43-7 (2003)
  6. Hsin O, La Greca AM, Valenzuela J, Moine C.T. and Delamater A., Adherence and glycemic control among Hispanic youth with type 1 diabetes: Role of family involvement and acculturation, J Pediatr Psychol, 35(2), 156-166 (2010)
  7. American Diabetes Association: Standards of medical care in diabetes, Diabetes Care, 36(1), 13-61 (2013)
  8. Khattab M, Khader Y.S, Al-Khawaldeh A, Ajlouni K., Factors associated with poor glycemic control among patients with type 2 diabetes, J Diabetes Complications, 24(2), 84-89 (2010)
  9. Roszyk L, Faye B, Sapin V, Somda F, Tauveron I., Glycated haemoglobin (HbA1c) today and tomorrow., Ann Endocrinol (Paris), 68(5), 357-65 (2007)
  10. Alam T, Weintraub N, Weinreb J., What is the proper use of hemoglobin A1c monitoring in the elderly? J Am Med Dir Assoc., 7(3),60-64(2006)
  11. Vucic M, Petrovic S, Mesic R, Rocic B., An automated immunoturbidimetric assay for HbA1c determination, Clin Chem Lab Med, 37, (1999)
  12. Barham D, Trinder P., An improved color reagent for the determination of blood glucose by the oxidase system, Analyst, 97(151):142-5(1972)
  13. Allain C.C, Poon L.S, Chan C.S.G, Richmond W, Fu P.C., Enzymatic determination of total serum cholesterol,Clin Chem., 20(4), 470-5 (1974)
  14. Bucolo G, David H., Quantitative determination of serum triglycerides by the use of enzymes, Clin Chem., 19(5),476-482 (1973)
  15. Demacker P.N., Hijmans A.G., Vos-Janssen H.E., Van't Laar A., Jansen A.P., A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein, Clin Chem., 26(13), 1775-1779 (1980)
  16. Friedewald W.T., Levy R.I., Fredrickson D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem,18(6), 499-502 (1972)
  17. Rao G.M., Serum electrolytes and osmolality in diabetes mellitus, Ind J Med Sci, 46(10), 301-303 (1992)
  18. Kendall D.M,Rubin C.J., Mohideen P., Ledeine L.M., Beller R., Gross J., Norwood P., O'Mahony M., Sall K., Sloan G.G., Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual ([alpha]/[gamma]) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazone-comparative study, Diabetes Care,29,1016–1023 (2006)
  19. Eckel R.H., Wassef M., Chait A., Prevention Conference VI: Diabetes and Cardiovascular Disease : Writing Group II :pathogenesis of atherosclerosis in diabetes, Circulation 105, 138-143(2002)
  20. Van Style D.D., Serdroy J., Studies on diabetes and electrolyte equilibrium in blood, J BiolChem, 18: 20-26 (1928)
  21. Leonard I.K., John M., Physiology and pathophysiology of body water and electrolytes. In: Kaplan and Pesce (Eds.), Clinical Chemistry: Theory, analysis and correlation, The C.V. Mosby Co. St Louis; 313-331 (1989)
  22. Cowie C.C., Harris M.I., Physical and metaboliccharacteristics of persons with diabetes, Diabetes in America, 2nd ed. National Institutes of Health; 117-164(1995)